| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |